PENDARVIS DAVID 4
4 · RESMED INC · Filed Nov 29, 2022
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Gift
ResMed Common Stock
2022-11-28−7,300→ 100,172 total - Exercise/Conversion
ResMed Common Stock
2022-11-25$146.34/sh+683$99,950→ 107,472 total - Exercise/Conversion
ResMed Common Stock Options
2022-11-25−683→ 12,540 totalExercise: $146.34From: 2020-11-11Exp: 2026-11-21→ ResMed Common Stock (683 underlying)
Footnotes (2)
- [F1]Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares.
- [F2]Represents date options first became exercisable. Options vest 1/3 per year.